Table 4 Holter data of the patients and controls.
Controls | STEMI patients | ||||
|---|---|---|---|---|---|
acute stage | 3rd month | 6th month | 12th month | ||
Time domain analysis | |||||
Mean NN, ms | 823 (746; 903) | 725 (684; 838) | 763 (691, 837) | 789 (710; 879) | 789 (697; 902) |
0.012 | 0.156 | 0.602 | 0.562 | ||
SDNN, ms | 85 (73; 107) | 52 (42; 73) | 84 (62; 99) | 81 (66; 101) | 91 (63; 125) |
<0.001 | 0.282 | 0.210 | 0.994 | ||
pNN20, % | 30.1 (18.9; 40.7) | 22.3 (15.4; 38.3) | 23.6 (14.8; 40.4) | 21.1 (16.3; 37.9) | 31.1 (12.1; 40.2) |
0.268 | 0.277 | 0.266 | 0.718 | ||
pNN50, % | 3.1 (1.6; 7.7) | 2.0 (1.4; 6.8) | 3.7 (1.2; 6.6) | 2.9 (1.1; 6.6) | 4.6 (1.8; 9.6) |
0.402 | 0.806 | 0.518 | 0.465 | ||
Frequency domain analysis | |||||
LF | 199 (123; 288) | 108 (71; 260) | 201 (68; 265) | 147 (54; 299) | 168 (90; 369) |
0.020 | 0.343 | 0.128 | 0.688 | ||
HF | 98 (51; 209) | 74 (45; 148) | 146 (40; 202) | 96 (38; 190) | 137 (74; 248) |
0.349 | 0.692 | 0.440 | 0.638 | ||
LF/HF | 1.52 (1.10; 3.36) | 1.55 (1.04; 2.78) | 1.42 (0.98; 2.01) | 1.68 (1.24; 2.17) | 1.30 (0.95; 2.14) |
0.409 | 0.180 | 0.665 | 0.068 | ||
Detrended fractal analysis | |||||
Alpha-1 | 0.99 (0.85; 1.20) | 0.99 (0.81; 1.10) | 0.90 (0.81; 0.98) | 0.98 (0.89; 1.10) | 0.85 (0.780; 1.01) |
0.343 | 0.041 | 0.702 | 0.032 | ||
Alpha-2 | 1.08 (1.04; 1.11) | 0.98 (0.89; 1.04) | 1.07 (1.01; 1.11) | 1.09 (1.03; 1.13) | 1.11 (1.01; 1.16) |
<0.001 | 0.583 | 0.347 | 0.116 | ||
Multiscale entropy | |||||
Slope 1–5 | 0.061 (0.030; 0.084) | 0.019 (−0.021; 0.049) | 0.032 (−0.005; 0.060) | 0.034 (−0.015; 0.054) | 0.031 (−0.017; 0.057) |
0.002 | 0.011 | 0.018 | 0.002 | ||
Area 1–5 | 4.54 (3.90; 4.93) | 4.93 (3.54; 5.68) | 3.97 (3.09; 4.36) | 3.82 (3.38; 4.52) | 3.98 (3.59; 4.23) |
0.375 | 0.002 | 0.003 | 0.008 | ||
Area 6–20 | 19.6 (18.3; 21.3) | 18.9 (17.1; 23.3) | 18.3 (15.1; 19.7) | 17.6 (16.1; 19.7) | 17.3 (15.6; 19.0) |
0.936 | 0.011 | 0.003 | 0.001 | ||